|
US296006A
(en)
|
|
1884-04-01 |
|
John hoefleb |
|
US3725540A
(en)
|
1970-07-30 |
1973-04-03 |
Procter & Gamble |
Color and odor stabilized dry aerosol antiperspirant
|
|
US3964482A
(en)
*
|
1971-05-17 |
1976-06-22 |
Alza Corporation |
Drug delivery device
|
|
CH587021A5
(https=)
|
1974-06-07 |
1977-04-29 |
Nestle Sa |
|
|
US4152170A
(en)
|
1975-06-18 |
1979-05-01 |
Sumitomo Chemical Company, Ltd. |
Cross-linked pullulan
|
|
JPS541064Y2
(https=)
|
1975-09-18 |
1979-01-19 |
|
|
|
US4172149A
(en)
|
1978-01-30 |
1979-10-23 |
Westwood Pharmaceuticals, Inc. |
Method for treating living skin exhibiting excessive sebum secretion
|
|
DE2929425A1
(de)
|
1979-07-20 |
1981-02-12 |
Lothar Kling |
Vorrichtung fuer injektionsspritzen zur intramuskulaeren und subentanen injektion
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
US4533254A
(en)
|
1981-04-17 |
1985-08-06 |
Biotechnology Development Corporation |
Apparatus for forming emulsions
|
|
US4908154A
(en)
|
1981-04-17 |
1990-03-13 |
Biotechnology Development Corporation |
Method of forming a microemulsion
|
|
ATE37983T1
(de)
|
1982-04-22 |
1988-11-15 |
Ici Plc |
Mittel mit verzoegerter freigabe.
|
|
JPH07116268B2
(ja)
|
1984-01-09 |
1995-12-13 |
大西 靖彦 |
デキストランの陰イオン性部分置換体とオレフィン化合物との共重合体の製法
|
|
US5554372A
(en)
|
1986-09-22 |
1996-09-10 |
Emory University |
Methods and vaccines comprising surface-active copolymers
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
JPH0798740B2
(ja)
|
1987-10-28 |
1995-10-25 |
日本新薬株式会社 |
薬物担体
|
|
IL88076A
(en)
|
1987-10-28 |
1993-01-14 |
Nippon Shinyaku Co Ltd |
Fat emulsions as drug carriers
|
|
US5651991A
(en)
|
1987-10-28 |
1997-07-29 |
Nippon Shinyaku Co. Ltd. |
Drug carriers
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5008110A
(en)
|
1988-11-10 |
1991-04-16 |
The Procter & Gamble Company |
Storage-stable transdermal patch
|
|
CH677886A5
(https=)
|
1989-06-26 |
1991-07-15 |
Hans Georg Prof Dr Weder |
|
|
FR2659554B1
(fr)
|
1990-03-16 |
1994-09-30 |
Oreal |
Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
|
|
US5401243A
(en)
|
1990-08-21 |
1995-03-28 |
Associated Synapse Biologics |
Controlled administration of chemodenervating pharmaceuticals
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
JP3765579B2
(ja)
|
1990-08-24 |
2006-04-12 |
イーデーエーアー アーゲー |
作用物質投与用超微小滴状調剤
|
|
JPH04202122A
(ja)
|
1990-11-28 |
1992-07-22 |
Procter & Gamble Co:The |
ジケトン脱臭組成物及び脱臭方法
|
|
JPH04198123A
(ja)
|
1990-11-28 |
1992-07-17 |
Procter & Gamble Co:The |
アミン脱臭組成物及び脱臭方法
|
|
JPH04198122A
(ja)
|
1990-11-28 |
1992-07-17 |
Procter & Gamble Co:The |
チオールヘテロ環脱臭組成物及び脱臭方法
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US5652274A
(en)
|
1991-03-01 |
1997-07-29 |
Martin; Alain |
Therapeutic-wound healing compositions and methods for preparing and using same
|
|
HK1001951A1
(en)
|
1991-05-03 |
1998-07-24 |
Raisio Benecol Ltd. |
A substance for lowering high cholesterol level in serum and a method for preparing the same
|
|
JPH04351623A
(ja)
|
1991-05-28 |
1992-12-07 |
Nippon Kayaku Co Ltd |
新規ブロック共重合体及びその製造方法
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
GB9120306D0
(en)
|
1991-09-24 |
1991-11-06 |
Graham Herbert K |
Method and compositions for the treatment of cerebral palsy
|
|
US6939852B2
(en)
|
1991-09-24 |
2005-09-06 |
Allergan, Inc. |
Methods and compositions for the treatment of cerebral palsy
|
|
US7384918B2
(en)
|
1991-09-24 |
2008-06-10 |
Allergan, Inc. |
Botulinum toxin for treating muscle contracture
|
|
US5613952A
(en)
|
1991-12-23 |
1997-03-25 |
Syringe Develpoment Partners |
Safety syringe
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
IL101387A
(en)
|
1992-03-26 |
1999-11-30 |
Pharmos Ltd |
Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
|
|
US6010715A
(en)
|
1992-04-01 |
2000-01-04 |
Bertek, Inc. |
Transdermal patch incorporating a polymer film incorporated with an active agent
|
|
EP0571677A1
(en)
|
1992-05-29 |
1993-12-01 |
Unilever Plc |
Aqueous parfume oil microemulsions
|
|
EP0572080B1
(en)
|
1992-05-29 |
1995-11-15 |
Quest International B.V. |
Aqueous perfume oil microemulsions
|
|
CA2138020C
(en)
*
|
1992-06-23 |
1999-02-16 |
Eric A. Johnson |
Pharmaceutical composition containing botulinum b complex
|
|
US5302401A
(en)
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
|
US5470577A
(en)
|
1993-07-07 |
1995-11-28 |
Trustees Of Boston University |
Stimulation of tanning by DNA fragments or single-stranded DNA
|
|
IT1261849B
(it)
|
1993-09-02 |
1996-06-03 |
Avantgarde Spa |
Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
|
|
US8187612B2
(en)
|
1993-12-28 |
2012-05-29 |
Allergan, Inc. |
Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
|
|
US6974578B1
(en)
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
|
JPH07285863A
(ja)
|
1994-02-25 |
1995-10-31 |
Takeda Chem Ind Ltd |
注射剤組成物およびその製造方法
|
|
FI963297A7
(fi)
|
1994-02-25 |
1996-10-18 |
Takeda Chemical Industries Ltd |
Antifungaalisia triatsolijohdannaisia sisältävät emulsiot
|
|
DE69529054T2
(de)
|
1994-02-28 |
2003-08-21 |
Nanopharm Ag |
System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
|
|
US5766605A
(en)
|
1994-04-15 |
1998-06-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Treatment of autonomic nerve dysfunction with botulinum toxin
|
|
US5670484A
(en)
|
1994-05-09 |
1997-09-23 |
Binder; William J. |
Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
|
|
ES2078190B1
(es)
|
1994-05-20 |
1996-08-01 |
Cusi Lab |
Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
|
|
DE69528062T2
(de)
|
1994-06-20 |
2003-04-30 |
Nippon Shinyaku Co., Ltd. |
Verfahren zum herstellen von emulsionen aus einem emulgator
|
|
US5672358A
(en)
|
1994-06-21 |
1997-09-30 |
Ascent Pharmaceuticals, Inc. |
Controlled release aqueous emulsion
|
|
ES2094688B1
(es)
|
1994-08-08 |
1997-08-01 |
Cusi Lab |
Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
|
|
US5512547A
(en)
|
1994-10-13 |
1996-04-30 |
Wisconsin Alumni Research Foundation |
Pharmaceutical composition of botulinum neurotoxin and method of preparation
|
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
|
US20020048596A1
(en)
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
|
US5629021A
(en)
|
1995-01-31 |
1997-05-13 |
Novavax, Inc. |
Micellar nanoparticles
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
FR2730932B1
(fr)
|
1995-02-27 |
1997-04-04 |
Oreal |
Nanoemulsion transparente a base de lipides amphiphiles non-ioniques fluides et utilisation en cosmetique ou en dermopharmacie
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
DE69627963T2
(de)
|
1995-06-06 |
2004-03-04 |
Pearce, L. Bruce, Cambridge |
Verbesserte zusammensetzungen und verfahren zur chemodenervation mit neurotoxinen
|
|
US5660858A
(en)
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
|
JPH10114648A
(ja)
|
1996-10-11 |
1998-05-06 |
Kao Corp |
皮膚外用組成物
|
|
AU731832B2
(en)
|
1996-11-12 |
2001-04-05 |
Tamarkin Pharmaceutical Innovation Ltd |
Method for treatment of dermatological disorders
|
|
FR2755854B1
(fr)
|
1996-11-15 |
1998-12-24 |
Oreal |
Nanoemulsion a base de lipides amphiphiles non-ioniques et cationiques et utilisations
|
|
KR20000057687A
(ko)
|
1996-12-19 |
2000-09-25 |
엔도 마사루 |
프린트 배선판 및 그 제조방법
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6461596B1
(en)
|
1997-02-18 |
2002-10-08 |
Andrea Taylor |
Composition and method for promoting hair growth
|
|
FR2760970B1
(fr)
|
1997-03-18 |
2000-03-10 |
Oreal |
Nanoemulsions a base de lipides amphiphiles non-ioniques et de silicones aminees et utilisations
|
|
US5994414A
(en)
|
1997-04-28 |
1999-11-30 |
Avon Products, Inc. |
Water-thin emulsion formed by high pressure homogenization process
|
|
GB9708066D0
(en)
|
1997-04-22 |
1997-06-11 |
Woolcombers Group Plc |
Compositions and their use
|
|
US6835395B1
(en)
|
1997-05-14 |
2004-12-28 |
The University Of British Columbia |
Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
|
|
CA2289702C
(en)
|
1997-05-14 |
2008-02-19 |
Inex Pharmaceuticals Corp. |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
|
AU3176097A
(en)
|
1997-06-13 |
1998-12-30 |
Medinova Medical Consulting Gmbh |
Drug targeting system, method of its preparation and its use
|
|
CN1068524C
(zh)
|
1997-06-23 |
2001-07-18 |
叶庆炜 |
一种治疗顽症牛皮癣的药物
|
|
EP1011695B2
(en)
|
1997-07-15 |
2009-11-04 |
The Regents of the University of Colorado |
Use of neurotoxin therapy for treatment of prostate disorders
|
|
US6007856A
(en)
|
1997-08-08 |
1999-12-28 |
The Procter & Gamble Company |
Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
|
|
US5948433A
(en)
|
1997-08-21 |
1999-09-07 |
Bertek, Inc. |
Transdermal patch
|
|
US5993852A
(en)
|
1997-08-29 |
1999-11-30 |
Pharmaderm Laboratories Ltd. |
Biphasic lipid vesicle composition for transdermal administration of an immunogen
|
|
US6007803A
(en)
|
1997-09-19 |
1999-12-28 |
Geltex Pharmaceuticals, Inc. |
Ionic polymers as toxin binding agents
|
|
IT1296914B1
(it)
|
1997-12-01 |
1999-08-03 |
Maria Rosa Gasco |
Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
EP1080720A4
(en)
|
1998-03-05 |
2002-06-05 |
Nippon Shinyaku Co Ltd |
FAT EMULSIONS FOR INHALATIVE ADMINISTRATION
|
|
US5965154A
(en)
|
1998-03-17 |
1999-10-12 |
Plc Holding, L.L.C. |
Adhesive matrix type transdermal patch and method of manufacturing same
|
|
ATE372377T1
(de)
|
1998-03-30 |
2007-09-15 |
Mibelle Ag Cosmetics |
Verwendung von nanoemulsionen zur bestimmung der biokompatibilität von lipophilen stoffen im zellkultur-test und dafür geeignete nanoemulsionen
|
|
FI111513B
(fi)
|
1998-05-06 |
2003-08-15 |
Raisio Benecol Oy |
Uudet fytosteroli- ja fytostanolirasvahappoesterikoostumukset, niitä sisältävät tuotteet sekä menetelmät niiden valmistamiseksi
|
|
US5932562A
(en)
|
1998-05-26 |
1999-08-03 |
Washington University |
Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
|
|
US6503231B1
(en)
*
|
1998-06-10 |
2003-01-07 |
Georgia Tech Research Corporation |
Microneedle device for transport of molecules across tissue
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9818548D0
(en)
|
1998-08-25 |
1998-10-21 |
Microbiological Res Authority |
Treatment of mucas hypersecretion
|
|
TW574036B
(en)
|
1998-09-11 |
2004-02-01 |
Elan Pharm Inc |
Stable liquid compositions of botulinum toxin
|
|
FR2783169B1
(fr)
|
1998-09-15 |
2001-11-02 |
Sederma Sa |
Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
|
|
US6242001B1
(en)
|
1998-11-30 |
2001-06-05 |
Mcneil-Ppc, Inc. |
Method for producing dispersible sterol and stanol compounds
|
|
DE19856897A1
(de)
|
1998-12-10 |
2000-06-15 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum zur Unterdrückung von Schnarchgeräuschen
|
|
JP2002533379A
(ja)
|
1998-12-23 |
2002-10-08 |
イデア アクチェンゲゼルシャフト |
生体内における局所的に非侵襲性である用途のための改善された製剤
|
|
FR2787728B1
(fr)
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2788007B1
(fr)
|
1999-01-05 |
2001-02-09 |
Oreal |
Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
US20030229141A1
(en)
|
1999-01-08 |
2003-12-11 |
Yu Ruey J. |
N-acetyl cysteine and its topical use
|
|
AU2963400A
(en)
|
1999-01-14 |
2000-08-01 |
Amcol International Corporation |
Improved controlled release compositions and method
|
|
US6395029B1
(en)
|
1999-01-19 |
2002-05-28 |
The Children's Hospital Of Philadelphia |
Sustained delivery of polyionic bioactive agents
|
|
US20020054914A1
(en)
|
1999-02-03 |
2002-05-09 |
Tulin Morcol |
Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
|
|
US6635676B2
(en)
|
1999-04-28 |
2003-10-21 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
|
US20040009936A1
(en)
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
|
EP1100475A1
(en)
|
1999-06-02 |
2001-05-23 |
Medinova Medical Consulting Gmbh |
Use of drug-loaded nanoparticles for the treatment of cancers
|
|
US6611707B1
(en)
|
1999-06-04 |
2003-08-26 |
Georgia Tech Research Corporation |
Microneedle drug delivery device
|
|
JP2003501376A
(ja)
|
1999-06-04 |
2003-01-14 |
スカイファーマ インコーポレーテッド |
疎水性薬物の持続性放出のための油コア組成物
|
|
US6256533B1
(en)
*
|
1999-06-09 |
2001-07-03 |
The Procter & Gamble Company |
Apparatus and method for using an intracutaneous microneedle array
|
|
WO2001001962A1
(en)
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
WO2001010413A2
(en)
|
1999-08-04 |
2001-02-15 |
Idea Ag |
Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers
|
|
US6358917B1
(en)
|
1999-08-24 |
2002-03-19 |
Jean D. A. Carruthers |
Cosmetic use of botulinum toxin for treatment of downturned mouth
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
US7838008B2
(en)
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating diverse cancers
|
|
US6429189B1
(en)
|
1999-12-10 |
2002-08-06 |
Botulinum Toxin Research Associates, Inc. |
Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
|
|
WO2001047561A1
(en)
|
1999-12-28 |
2001-07-05 |
Bioniche Life Sciences Inc. |
Hyaluronic acid in the treatment of cancer
|
|
US6898427B1
(en)
|
1999-12-29 |
2005-05-24 |
Bellsouth Intellectual Property Corporation |
Method of coupling portable communications device to first network by way of second network
|
|
US6967023B1
(en)
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
|
FR2804015B1
(fr)
|
2000-01-21 |
2005-12-23 |
Oreal |
Nanoemulsion contenant des lipides amphiphiles et un polymere non ionique et utilisations
|
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
FR2805761B1
(fr)
|
2000-03-02 |
2002-08-30 |
Mainelab |
Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
|
|
MXPA02009275A
(es)
|
2000-03-23 |
2004-09-06 |
Collaborative Technologies Inc |
Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
|
|
US6464986B1
(en)
|
2000-04-14 |
2002-10-15 |
Allegan Sales, Inc. |
Method for treating pain by peripheral administration of a neurotoxin
|
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
|
FR2809112B1
(fr)
|
2000-05-16 |
2004-05-07 |
Centre Nat Rech Scient |
Materiaux a base de polymeres biodegradables et son procede de preparation
|
|
FR2809010B1
(fr)
|
2000-05-22 |
2002-07-12 |
Oreal |
Nanoemulsion a base de polymeres anioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
US6670322B2
(en)
|
2000-06-01 |
2003-12-30 |
Wisconsin Alumni Research Foundation |
Method of targeting pharmaceuticals to motor neurons
|
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
|
US20020155084A1
(en)
|
2000-06-02 |
2002-10-24 |
The Regents Of The University Of The Michigan |
Nanoemulsion formulations
|
|
US20040033241A1
(en)
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
FR2811561B1
(fr)
|
2000-07-13 |
2003-03-21 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
|
|
US20040220100A1
(en)
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
|
US6455058B1
(en)
|
2000-09-13 |
2002-09-24 |
Amitee Cosmetics, Inc. |
Composition and method for hair and scalp treatment
|
|
CA2427858A1
(en)
|
2000-11-03 |
2002-05-10 |
University Of Vermont And State Agricultural College |
Compositions for inhibiting grb7
|
|
FR2816949B1
(fr)
|
2000-11-17 |
2003-11-28 |
Centre Nat Rech Scient |
Copolymere a structure sequencee compose d'un segment saccharidique lie a au moins un segment hydrophobe bioerodable, et particules correspondantes
|
|
US20020086036A1
(en)
|
2000-12-05 |
2002-07-04 |
Allergan Sales, Inc. |
Methods for treating hyperhidrosis
|
|
US7255865B2
(en)
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
|
DK1345597T3
(da)
|
2000-12-27 |
2007-12-10 |
Ares Trading Sa |
Amfifile lipidanopartikler til peptid- og/eller proteininkorporering
|
|
FI20010115A0
(fi)
|
2001-01-18 |
2001-01-18 |
Orion Corp |
Menetelmä nanopartikkelien valmistamiseksi
|
|
FR2819427B1
(fr)
|
2001-01-18 |
2003-04-11 |
Oreal |
Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
US8216797B2
(en)
|
2001-02-07 |
2012-07-10 |
Massachusetts Institute Of Technology |
Pathogen detection biosensor
|
|
US20030072841A1
(en)
|
2001-03-19 |
2003-04-17 |
The Procter & Gamble Campany |
Polybutene containing chewing gum and confection
|
|
CA2445125A1
(en)
|
2001-03-21 |
2002-10-03 |
University Of Kentucky Research Foundation |
Microemulsions as precursors to solid nanoparticles
|
|
US20040048836A1
(en)
|
2001-03-23 |
2004-03-11 |
Wilmott James M |
Method for preparing high pressure/ high shear dispersions containing physiologically active ingredients
|
|
EP1377255A4
(en)
|
2001-03-30 |
2008-11-19 |
Color Access Inc |
NEW NANOEMULSIONS
|
|
KR100463167B1
(ko)
|
2001-04-13 |
2004-12-23 |
주식회사 태평양 |
고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
|
|
WO2004030608A2
(en)
|
2001-06-05 |
2004-04-15 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
US6767341B2
(en)
*
|
2001-06-13 |
2004-07-27 |
Abbott Laboratories |
Microneedles for minimally invasive drug delivery
|
|
EP1269994A3
(en)
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
|
KR100566911B1
(ko)
|
2001-06-25 |
2006-04-03 |
주식회사 삼양사 |
약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
|
|
US7226605B2
(en)
|
2001-07-27 |
2007-06-05 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Botulinum toxin in the treatment or prevention of acne
|
|
US7063860B2
(en)
|
2001-08-13 |
2006-06-20 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
|
US20150037402A1
(en)
|
2001-08-13 |
2015-02-05 |
Lipella Pharmaceuticals, Inc. |
Methods and Compositions for Treating Gastric Disorders
|
|
DE10146647A1
(de)
|
2001-09-21 |
2003-04-24 |
Marc Heckmann |
Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis
|
|
US20030077240A1
(en)
|
2001-10-24 |
2003-04-24 |
Clariant International, Ltd. |
Use of high-purity phenylsilsesquioxane liquids for the preparation of cosmetic and pharmaceutical compositions
|
|
US7235230B2
(en)
|
2001-10-24 |
2007-06-26 |
Clariant Finance (Bvi) Limited |
Leave-on compositions for personal care
|
|
CA2465123A1
(en)
|
2001-10-30 |
2003-05-08 |
Pentapharm Ag |
Dermopharmaceutically and cosmetically active oligopeptides
|
|
US6745211B2
(en)
*
|
2001-11-21 |
2004-06-01 |
Ge Financial Assurance Holdings, Inc. |
Method and system for verifying and correcting data records in a database
|
|
US20030113349A1
(en)
|
2001-12-18 |
2003-06-19 |
Coleman William P. |
Topically applied clostridium botulinum toxin compositions and treatment methods
|
|
US7763663B2
(en)
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
|
US6765001B2
(en)
|
2001-12-21 |
2004-07-20 |
Medicis Pharmaceutical Corporation |
Compositions and methods for enhancing corticosteroid delivery
|
|
KR100441167B1
(ko)
|
2001-12-27 |
2004-07-21 |
씨제이 주식회사 |
마이크로에멀젼 예비 농축액 조성물
|
|
US6908453B2
(en)
|
2002-01-15 |
2005-06-21 |
3M Innovative Properties Company |
Microneedle devices and methods of manufacture
|
|
EP1334729A1
(en)
|
2002-02-07 |
2003-08-13 |
Botulinum Toxin Research Associates, Inc. |
Therapeutic use of non-neurotoxic clostridium botulinum toxin type C2
|
|
WO2003071267A1
(en)
|
2002-02-19 |
2003-08-28 |
Vanderbilt University |
Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
|
|
US6861066B2
(en)
|
2002-03-11 |
2005-03-01 |
Health Plus International Inc. |
Method for the delivery of a biologically active agent
|
|
US6688311B2
(en)
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
|
US6623780B1
(en)
|
2002-03-26 |
2003-09-23 |
Cargill, Inc. |
Aqueous dispersible sterol product
|
|
US20040115159A1
(en)
|
2002-03-29 |
2004-06-17 |
Tadlock Charles C |
Novel nanoemulsions
|
|
US6875438B2
(en)
|
2002-04-27 |
2005-04-05 |
Aventis Pharma Deutschland Gmbh |
Preparations for topical administration of substances having antiandrogenic activity
|
|
US20060083778A1
(en)
|
2002-05-03 |
2006-04-20 |
Dean Allison |
Controlled release compositions of estradiol metabolites
|
|
EP1509236A4
(en)
|
2002-05-13 |
2008-07-30 |
Children S Hospital Los Angele |
TREATMENT AND PREVENTION OF ABNORMAL SCALING IN KELOIDS AND OTHER SKIN OR INTERNAL WOUNDS OR LESIONS
|
|
US7691394B2
(en)
|
2002-05-28 |
2010-04-06 |
Botulinum Toxin Research Associates, Inc. |
High-potency botulinum toxin formulations
|
|
US7459164B2
(en)
|
2002-05-28 |
2008-12-02 |
Botulinum Toxin Research Associates, Inc. |
Composition for therapeutic and cosmetic botulinum toxin
|
|
WO2003101483A1
(en)
|
2002-05-31 |
2003-12-11 |
Solux Corporation |
Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use
|
|
CA2488617A1
(en)
|
2002-06-10 |
2003-12-18 |
Eugene R. Cooper |
Nanoparticulate sterol formulations and sterol combinations
|
|
MXPA04012567A
(es)
|
2002-06-11 |
2005-04-19 |
Ethypharm Sa |
Nanocapsulas lipidicas encubiertas, metodos para la preparacion de las mismas y uso de las mismas como un portador para principios activos.
|
|
US6996748B2
(en)
|
2002-06-29 |
2006-02-07 |
Intel Corporation |
Handling faults associated with operation of guest software in the virtual-machine architecture
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US7824693B2
(en)
|
2002-08-19 |
2010-11-02 |
Ira Sanders |
Treatment of fine wrinkles with clostridia neurotoxins
|
|
JP4824311B2
(ja)
|
2002-09-12 |
2011-11-30 |
スリーエム イノベイティブ プロパティズ カンパニー |
低温特性および耐溶剤性を有するフルオロエラストマー
|
|
EP1590034B1
(en)
*
|
2002-10-07 |
2014-05-14 |
Biovalve Technologies, Inc. |
Microneedle array patch
|
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US20070292359A1
(en)
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
US20040115727A1
(en)
|
2002-12-11 |
2004-06-17 |
Allergan, Inc., A Corporation |
Evolved clostridial toxins with altered protease specificity
|
|
DE10258960A1
(de)
|
2002-12-16 |
2004-07-01 |
Henkel Kgaa |
Nanoskalige Hydrogele gegen Falten, raue und trockene Haut
|
|
US7329688B2
(en)
|
2002-12-17 |
2008-02-12 |
Soft Gel Technologies, Inc. |
Natural vitamin E compositions with superior antioxidant potency
|
|
CA2510058C
(en)
|
2002-12-20 |
2010-03-16 |
Botulinum Toxin Research Associates, Inc. |
Improved pharmaceutical botulinum toxin compositions
|
|
FR2849375B1
(fr)
|
2002-12-30 |
2006-10-20 |
Jean Noel Thorel |
Compositions cosmetiques, par exemple pour traiter le vieillissement cutane photo-induit
|
|
US7390505B2
(en)
|
2003-01-31 |
2008-06-24 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
|
EP1594552A2
(en)
|
2003-02-05 |
2005-11-16 |
Amphora Discovery Corporation |
Topical delivery of cosmetic agents
|
|
EP1599213A4
(en)
|
2003-02-24 |
2009-07-15 |
Ira Sanders |
CELL MEMBRANE TRANSLOCATION OF SNARE R GUL S INHIBITORS, ASSOCIATED COMPOSITIONS AND PATHOLOGY TREATMENT PROCESSES
|
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
US20040247623A1
(en)
|
2003-03-24 |
2004-12-09 |
Roger Cady |
Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
|
|
US20040191330A1
(en)
|
2003-03-31 |
2004-09-30 |
Keefe Candace R. |
Daily skin care regimen
|
|
AU2004226605A1
(en)
|
2003-04-02 |
2004-10-14 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
|
KR100720213B1
(ko)
|
2003-04-04 |
2007-05-21 |
화이자 프로덕츠 인코포레이티드 |
미세 유동화된 수중 유적형 유화액 및 백신 조성물
|
|
PL3524611T3
(pl)
|
2003-05-20 |
2021-06-14 |
Immunogen, Inc. |
Udoskonalone czynniki cytotoksyczne zawierające nowe maitansynoidy
|
|
GB0312309D0
(en)
|
2003-05-29 |
2003-07-02 |
Gaslini Children S Hospital G |
Targeted liposome
|
|
US20050079228A1
(en)
|
2003-05-30 |
2005-04-14 |
Ashish Jaiswal |
Clear, stable topical compositions of clarithromycin and processes for their preparation
|
|
AU2004273779B2
(en)
|
2003-06-04 |
2009-10-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
|
|
US20050208083A1
(en)
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
|
WO2004112821A1
(ja)
|
2003-06-20 |
2004-12-29 |
Santen Pharmaceutical Co., Ltd. |
筋緊張亢進性疾患の治療剤
|
|
EP1720605A4
(en)
|
2003-06-23 |
2007-10-24 |
Transpharma Medical Ltd |
TRANSDERMAL DELIVERY SYSTEM FOR COSMETIC AGENTS
|
|
US20050013850A1
(en)
|
2003-07-15 |
2005-01-20 |
Caers Jan K. |
Device to assist hyperhydrosis therapy
|
|
WO2005013938A1
(ja)
|
2003-08-06 |
2005-02-17 |
Eisai Co., Ltd. |
薬物超微粒子の製造法及び製造装置
|
|
WO2005014051A1
(en)
|
2003-08-08 |
2005-02-17 |
Barnes-Jewish Hospital |
Emulsion particles for imaging and therapy and methods of use thereof
|
|
US7419996B2
(en)
|
2003-08-13 |
2008-09-02 |
The University Of Houston |
Parenteral and oral formulations of benzimidazoles
|
|
CH715855B1
(de)
|
2003-08-28 |
2020-08-14 |
Mibelle Ag |
Zubereitung bestehend aus mindestens zwei Nanoemulsionen.
|
|
EP1510206A1
(en)
|
2003-08-29 |
2005-03-02 |
Novagali Pharma SA |
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
|
|
JP2006199589A
(ja)
|
2003-09-03 |
2006-08-03 |
Ltt Bio-Pharma Co Ltd |
生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤
|
|
US7160699B2
(en)
|
2003-09-25 |
2007-01-09 |
Allergan, Inc. |
Media for clostridium bacterium and processes for obtaining a clostridial toxin
|
|
BRPI0415858A
(pt)
|
2003-10-29 |
2007-01-09 |
Sonus Pharma Inc |
compostos de medicamentos terapêuticos modificados por tocoferol
|
|
JP4256389B2
(ja)
|
2003-11-17 |
2009-04-22 |
セダーマ |
テトラペプチドとトリペプチドの混合物を含む組成物
|
|
NO20035681D0
(no)
|
2003-12-18 |
2003-12-18 |
Amersham Health As |
Optisk avbildning av lungekreft
|
|
US20050136024A1
(en)
|
2003-12-22 |
2005-06-23 |
Stockel Richard F. |
Dermatological compositions
|
|
EP1547674A1
(en)
|
2003-12-23 |
2005-06-29 |
MediGene Oncology GmbH |
Method for producing colloidal nanoparticles
|
|
US6974579B2
(en)
|
2004-01-08 |
2005-12-13 |
Allergan, Inc. |
Methods for treating vascular disorders
|
|
FR2865131B1
(fr)
|
2004-01-15 |
2007-08-24 |
Gattefosse Ets Sa |
Utilisation d'un extrait d'acmella oleracea pour son effet botox like dans une composition cosmetique anti-rides
|
|
EP1713446B1
(en)
|
2004-01-23 |
2010-12-01 |
Camurus Ab |
Ternary non-lamellar lipid compositions
|
|
WO2005074894A1
(en)
|
2004-01-30 |
2005-08-18 |
Corium International |
Rapidly dissolving film for delivery of an active agent
|
|
JP2007520555A
(ja)
|
2004-02-05 |
2007-07-26 |
バクスター・インターナショナル・インコーポレイテッド |
自己安定化剤の使用により調製された分散剤
|
|
EP1718163A1
(en)
|
2004-02-23 |
2006-11-08 |
The Texas A&M University System |
Antioxidant compositions and methods of use thereof
|
|
DE102004009287A1
(de)
|
2004-02-26 |
2005-09-15 |
Institut Für Neue Materialien Gem. Gmbh |
Amphiphile Nanopartikel
|
|
CN1946431B
(zh)
|
2004-03-03 |
2011-12-07 |
雷文斯治疗公司 |
用于肉毒毒素的局部施用和透皮递送的组合物和方法
|
|
US20050214325A1
(en)
|
2004-03-26 |
2005-09-29 |
Vvii Newco 2003, Inc. |
Compositions and methods to increase the effect of a neurotoxin treatment
|
|
BRPI0509019A
(pt)
|
2004-03-22 |
2007-08-07 |
Celgene Corp |
métodos para tratar, prevenir ou controlar um distúrbio ou doença de pele, para tratar, prevenir ou controlar ceratose senil e para tratar ou controlar ceratose, composição farmacêutica, forma de dosagem unitária individual, e, kit
|
|
DE102004016710B4
(de)
|
2004-04-05 |
2020-11-19 |
Greppmayr GmbH |
Formulierung zur Fußpflege
|
|
EP1586336A1
(en)
|
2004-04-06 |
2005-10-19 |
JOHNSON & JOHNSON GmbH |
Compositions containing copper salts and soy products
|
|
TW200603843A
(en)
|
2004-04-20 |
2006-02-01 |
Technology Dev Company Ltd |
Tissue enhancement implant and method
|
|
US20050249686A1
(en)
|
2004-04-27 |
2005-11-10 |
Francoise Pataut |
Cosmetic composition free of water comprising fatty acid esters, petrolatum oil and non-ionic polymers
|
|
US7591806B2
(en)
|
2004-05-18 |
2009-09-22 |
Bai Xu |
High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
|
|
US7228259B2
(en)
|
2004-06-30 |
2007-06-05 |
Lucent Technologies Inc. |
Method and apparatus for structure-preserving reduced-order modeling
|
|
GB2416122A
(en)
|
2004-07-12 |
2006-01-18 |
Ipsen Ltd |
Botulinum neurotoxin composition
|
|
AU2005275193A1
(en)
|
2004-07-15 |
2006-02-23 |
Nanobac Life Sciences |
Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
|
|
BRPI0513850A
(pt)
|
2004-07-26 |
2008-05-20 |
Merz Pharma Gmbh & Co Kgaa |
composição terapêutica com uma neurotoxina botulìnica
|
|
KR100623013B1
(ko)
|
2004-09-04 |
2006-09-19 |
김영대 |
나노에멀션, 그의 용도 및 제조방법
|
|
CA2518650A1
(en)
|
2004-09-10 |
2006-03-10 |
Dimitrios Dimitrakoudis |
Clostridium botulinum toxin formulation and method for reducing weight
|
|
AU2005286640A1
(en)
|
2004-09-21 |
2006-03-30 |
Anesiva, Inc. |
Delivery of polynucleotides
|
|
US20060073208A1
(en)
|
2004-10-01 |
2006-04-06 |
Allergan, Inc. |
Cosmetic neurotoxin compositions and methods
|
|
WO2006040688A2
(en)
|
2004-10-12 |
2006-04-20 |
Ernir Snorrason |
Inhibitors of acetylcholinesterase for treating skin diseases
|
|
US20060084353A1
(en)
|
2004-10-18 |
2006-04-20 |
Wong Tak K |
Reversible ball having hyper-elastic properties
|
|
GB0423554D0
(en)
|
2004-10-22 |
2004-11-24 |
Cancer Rec Tech Ltd |
Therapeutic compounds
|
|
BRPI0404595A
(pt)
|
2004-10-26 |
2006-06-13 |
Natura Cosmeticos Sa |
nanoemulsão óleo-em-água, composição cosmética e produto cosmético compreendendo a mesma, processo para preparação da dita nanoemulsão
|
|
JP2008519784A
(ja)
|
2004-11-12 |
2008-06-12 |
イデア アクチェンゲゼルシャフト |
皮膚状態の治療における拡張表面凝集体
|
|
EP1848407A2
(en)
|
2005-02-02 |
2007-10-31 |
Mega Lifesciences Pvt. Ltd. |
Oral pharmaceutical composition
|
|
US7838011B2
(en)
|
2005-02-14 |
2010-11-23 |
Pankaj Modi |
Stabilized protein compositions for topical administration and methods of making same
|
|
PL1853303T3
(pl)
|
2005-02-14 |
2016-05-31 |
Dpm Therapeutics Corp |
Stabilizowane kompozycje do podawania miejscowego i sposoby ich otrzymywania
|
|
CA2494473C
(en)
|
2005-02-14 |
2007-06-26 |
Dpm Therapeutics Corp. |
Stabilized protein compositions for topical administration and methods of making same
|
|
US7727537B2
(en)
|
2005-02-14 |
2010-06-01 |
Dpm Therapeutics Corp. |
Stabilized compositions for topical administration and methods of making same
|
|
US20080220021A1
(en)
|
2005-02-14 |
2008-09-11 |
Pankaj Modi |
Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
|
|
US9314431B2
(en)
|
2005-02-14 |
2016-04-19 |
Transdermal Corp |
Solubilized benzoyl small molecule
|
|
CN101160318A
(zh)
|
2005-03-03 |
2008-04-09 |
雷文斯治疗公司 |
用于局部施用和经皮肤递送寡肽的组合物和方法
|
|
SG160357A1
(en)
|
2005-03-03 |
2010-04-29 |
Revance Therapeutics Inc |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
JP4444149B2
(ja)
|
2005-03-30 |
2010-03-31 |
株式会社ナリス化粧品 |
超微細エマルジョンで構成される皮膚外用剤
|
|
US8926991B2
(en)
|
2005-06-14 |
2015-01-06 |
Botulinum Toxin Research Associates, Inc. |
Botulinum toxin and the treatment of primary disorders of mood and affect
|
|
CA2948238A1
(en)
|
2005-06-14 |
2006-12-28 |
Revance Therapeutics, Inc. |
Botulinum toxin and the treatment of primary disorders of mood and affect
|
|
US8105611B2
(en)
|
2005-06-17 |
2012-01-31 |
Allergan, Inc. |
Treatment of autoimmune disorder with a neurotoxin
|
|
BRPI0613631A8
(pt)
|
2005-07-18 |
2017-12-26 |
Univ Massachusetts Lowell |
nanoemulsão e método,
|
|
US8323666B2
(en)
|
2005-08-01 |
2012-12-04 |
Allergan, Inc. |
Botulinum toxin compositions
|
|
WO2007015441A1
(ja)
*
|
2005-08-01 |
2007-02-08 |
Hisamitsu Pharmaceutical Co., Inc. |
経皮または経粘膜投与のためのアジュバントおよび製剤
|
|
JP2009504805A
(ja)
|
2005-08-09 |
2009-02-05 |
ナノバイオ コーポレーション |
抗炎症活性を有するナノエマルジョン組成物
|
|
WO2007035311A2
(en)
|
2005-09-16 |
2007-03-29 |
University Of Massachusetts Lowell |
Anti-oxidant synergy formulation nanoemulsions to treat cancer
|
|
US8137677B2
(en)
|
2005-10-06 |
2012-03-20 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
|
EP1933813A4
(en)
|
2005-10-11 |
2013-02-27 |
Univ Pittsburgh |
SPHINGOMYELIN LIPOSOME FOR THE TREATMENT OF HYPERACTIVE BLADDER DISORDER
|
|
DE102006046076A1
(de)
|
2005-10-14 |
2007-04-19 |
Henkel Kgaa |
Kosmetische und dermatologische Zusammensetzungen mit Oligopeptiden und Apfelextrakt
|
|
CN101340884A
(zh)
|
2005-10-19 |
2009-01-07 |
曼尼·马纳舍·辛格尔 |
用于治疗多汗症的方法
|
|
CN101304738A
(zh)
|
2005-11-09 |
2008-11-12 |
霍尔莫斯医疗有限公司 |
非培米芬的制剂
|
|
US20070148194A1
(en)
|
2005-11-29 |
2007-06-28 |
Amiji Mansoor M |
Novel nanoemulsion formulations
|
|
BRPI0619134B8
(pt)
|
2005-12-01 |
2021-05-25 |
Univ Massachusetts Lowell |
nanoemulsão, composição farmacêutica, composição, métodos cosméticos para o tratamento de rugas, linhas faciais e/ou linhas do pescoço, e de retardar o início das rugas, linhas faciais e/ou linhas do pescoço, e, método de fabricação de uma nanoemulsão
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
US20070178121A1
(en)
|
2006-01-27 |
2007-08-02 |
Allergan, Inc. |
Methods for enhancing skin treatments
|
|
JP2009527275A
(ja)
|
2006-02-17 |
2009-07-30 |
ゾゲニクス インコーポレーティッド |
神経毒の送達のための方法およびシステム
|
|
US7939567B2
(en)
|
2006-02-24 |
2011-05-10 |
Blue Blood Biotech Corp. |
Dextromethorphan-based method for treating acne
|
|
EP1998742A2
(en)
|
2006-03-08 |
2008-12-10 |
Nuviance, INC. |
Transdermal drug delivery compositions and topical compositions for application on the skin
|
|
EP2015773A4
(en)
|
2006-04-27 |
2010-05-05 |
Anterios Inc |
EXAMINATION OF THE EFFECTS OF TOPICAL ADMINISTRATION OF CHEMICALLY DENOMINATING PHARMACEUTICALS
|
|
US20110135742A1
(en)
|
2006-06-20 |
2011-06-09 |
The Regents Of The University Of California |
Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
|
|
PT2494959E
(pt)
|
2006-07-05 |
2015-02-20 |
Foamix Pharmaceuticals Ltd |
Veículo formador de espuma de ácido dicarboxílico e suas composições farmacêuticas
|
|
US20100183726A1
(en)
|
2006-08-02 |
2010-07-22 |
Robert Nicolosi |
Compositions and methods for treating cancer with dacarbazine nanoemulsions
|
|
CN101553275A
(zh)
*
|
2006-08-29 |
2009-10-07 |
纳生微电子有限公司 |
用于活性物质透皮递送和取样的高纵横比微器件和方法
|
|
KR101456728B1
(ko)
|
2006-09-08 |
2014-10-31 |
메디뮨 엘엘씨 |
인간화 항-ｃｄ19 항체, 및 이것의 종양학, 이식 및 자가면역 질환의 치료에서의 용도
|
|
US7445783B2
(en)
|
2006-10-30 |
2008-11-04 |
Cappellos, Inc. |
Topical and transdermal treatments using urea formulations
|
|
EP2073794A2
(en)
|
2006-11-14 |
2009-07-01 |
Foamix Ltd. |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
|
SG10201607909WA
(en)
|
2006-12-01 |
2016-11-29 |
Anterios Inc |
Peptide nanoparticles and uses therefor
|
|
WO2008070538A2
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Micellar nanoparticles comprising botulinum toxin
|
|
US9364461B2
(en)
|
2006-12-21 |
2016-06-14 |
Santen Sas |
Process for manufacturing ophthalmic oil-in-water emulsions
|
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
|
WO2008151022A2
(en)
|
2007-05-31 |
2008-12-11 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
|
US9511016B2
(en)
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
|
JP5101693B2
(ja)
|
2007-06-20 |
2012-12-19 |
コンパニー ゼネラール デ エタブリッスマン ミシュラン |
多車軸車両の全タイヤｉｄのオートロケーション
|
|
WO2009009417A2
(en)
|
2007-07-06 |
2009-01-15 |
Wyeth |
Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion
|
|
CN101842107B
(zh)
*
|
2007-07-26 |
2014-04-23 |
雷文斯治疗公司 |
抗微生物肽，组合物和使用方法
|
|
US20120150023A1
(en)
|
2007-08-06 |
2012-06-14 |
Kaspar Roger L |
Microneedle arrays for active agent delivery
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
EP2630966B1
(en)
|
2007-10-12 |
2017-04-19 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
|
EP2227766A2
(en)
|
2007-11-05 |
2010-09-15 |
Wista Laboratories Ltd. |
Systems for clinical trials
|
|
TWI543768B
(zh)
|
2007-11-30 |
2016-08-01 |
艾伯維生物技術有限責任公司 |
蛋白質調配物及製造其之方法
|
|
CA2719803A1
(en)
|
2008-03-28 |
2009-10-01 |
University Of Massachusetts |
Compositions and methods for the preparation of nanoemulsions
|
|
US20170361130A9
(en)
|
2008-05-23 |
2017-12-21 |
Pankaj Modi |
Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
|
|
AU2009248810B2
(en)
|
2008-05-23 |
2013-12-05 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
EP2293814A4
(en)
|
2008-05-23 |
2013-02-13 |
Univ Michigan |
NANOEMULSION AGENTS
|
|
MX379265B
(es)
|
2008-06-26 |
2025-03-11 |
Anterios Inc |
Aplicacion dérmica de toxina botulínica en nanoemulsiones para usarse en el tratamiento de trastornos de la piel.
|
|
WO2010025128A1
(en)
|
2008-08-25 |
2010-03-04 |
Critical Biologics Corporation |
Methods for reducing sample size of clinical trials
|
|
US20110206736A1
(en)
|
2008-09-23 |
2011-08-25 |
Thomas Jefferson University |
Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same
|
|
ES2342754B1
(es)
|
2008-10-03 |
2011-05-11 |
Lipotec, S.A. |
Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas, cuero cabelludo y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
|
|
JP5879126B2
(ja)
*
|
2008-10-07 |
2016-03-08 |
ジン・トゥオＪＩＮ Ｔｕｏ |
相転移ポリマーマイクロニードル
|
|
WO2010056922A2
(en)
*
|
2008-11-12 |
2010-05-20 |
Kythera Biopharmaceuticals, Inc. |
Systems and methods for delivery of biologically active agents
|
|
US20100137357A1
(en)
|
2008-11-26 |
2010-06-03 |
Koleng John J |
Compositions and methods for hyperhidrosis
|
|
AU2009332947C1
(en)
*
|
2008-12-31 |
2019-01-03 |
Revance Therapeutics, Inc. |
Injectable botulinum toxin formulations
|
|
US20100226983A1
(en)
|
2009-01-28 |
2010-09-09 |
Nanobio Corporation |
Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
|
|
ES2349972B1
(es)
|
2009-02-16 |
2011-11-24 |
Lipotec, S.A. |
Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
|
|
US20130045238A1
(en)
|
2009-04-22 |
2013-02-21 |
Agency For Science, Technology And Research |
Emulsions for transdermal delivery
|
|
NZ613647A
(en)
|
2009-05-06 |
2015-02-27 |
Biotest Ag |
Uses of immunoconjugates targeting cd138
|
|
EP2445521A4
(en)
*
|
2009-06-25 |
2015-08-26 |
Revance Therapeutics Inc |
ALBUMINE-FREE BOTULINUM TOXIN FORMULATIONS
|
|
US9125907B2
(en)
|
2009-09-30 |
2015-09-08 |
Christopher Shaari |
Use of botulinum neurotoxin to treat substance addictions
|
|
WO2011050180A1
(en)
|
2009-10-21 |
2011-04-28 |
Immunogen, Inc. |
Novel dosing regimen and method of treatment
|
|
EP2529222A4
(en)
|
2010-01-26 |
2013-10-09 |
Ridge Diagnostics Inc |
MULTIPLE BIOMARKER PANELS FOR STRATIFYING ILLNESS HEAVY GRADES AND MONITORING THE TREATMENT OF DEPRESSIONS
|
|
EP2575872B1
(en)
|
2010-06-01 |
2020-08-19 |
Seqirus UK Limited |
Concentration of influenza vaccine antigens without lyophilization
|
|
US20110305735A1
(en)
|
2010-06-09 |
2011-12-15 |
Lipotec, S.A. |
Skin antiaging treatment
|
|
US20130078295A1
(en)
|
2010-06-09 |
2013-03-28 |
Lipotec S.A. |
Skin antiaging treatment
|
|
US20120064136A1
(en)
|
2010-09-10 |
2012-03-15 |
Nanobio Corporation |
Anti-aging and wrinkle treatment methods using nanoemulsion compositions
|
|
ES2390033B1
(es)
|
2010-11-30 |
2013-10-31 |
Lipotec S.A. |
Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas.
|
|
EP2667854B1
(en)
|
2011-01-24 |
2019-01-16 |
Anterios, Inc. |
Nanoparticle compositions
|
|
CN103533926A
(zh)
|
2011-01-24 |
2014-01-22 |
安特里奥公司 |
空纳米颗粒组合物及其用于治疗皮肤病学病症的用途
|
|
KR20140004186A
(ko)
|
2011-01-24 |
2014-01-10 |
안테리오스, 인코퍼레이티드 |
표면활성제 조성물
|
|
US20120328549A1
(en)
|
2011-01-24 |
2012-12-27 |
Anterios, Inc. |
Oil compositions
|
|
JP2014507420A
(ja)
|
2011-01-24 |
2014-03-27 |
アンテリオス， インコーポレイテッド |
パラベン組成物
|
|
KR20140005998A
(ko)
|
2011-01-24 |
2014-01-15 |
안테리오스, 인코퍼레이티드 |
나노입자 조성물, 이의 제형, 및 그의 용도
|
|
BR112013020770A2
(pt)
|
2011-02-15 |
2019-08-27 |
Allergan, Inc. |
composições de creme farmacêutico de oximetazolina para tratamento de sintomas de rosácea
|
|
AU2012283968B2
(en)
|
2011-07-20 |
2016-04-14 |
Allergan, Inc. |
Botulinum toxins for use in a method for treatment of adipose deposits
|
|
EP2550975A1
(en)
|
2011-07-29 |
2013-01-30 |
Sanofi |
Combination therapy for the treatment of CD19+ B-cell malignancies symptoms comprising an anti-CD19 maytansinoid immunoconjugate and rituximab
|
|
WO2013096026A1
(en)
|
2011-12-21 |
2013-06-27 |
3M Innovative Properties Company |
Transdermal adhesive patch assembly with removable microneedle array and method of using same
|
|
CN104127859B
(zh)
|
2011-12-27 |
2015-08-19 |
中国药科大学 |
多肽在制备治疗或预防类风湿性关节炎药物中的应用
|
|
AU2013234988A1
(en)
|
2012-03-22 |
2014-10-09 |
Revance Therapeutics, Inc. |
Method of treatment of wrinkles using topical chemodenervating agents
|
|
EP2649985A1
(en)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Compounds which inhibit neuronal exocytosis (III)
|
|
AU2013248301B2
(en)
|
2012-04-16 |
2017-11-09 |
Lubrizol Advanced Materials, Inc. |
Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
|
|
WO2015020982A2
(en)
|
2013-08-04 |
2015-02-12 |
Aquavit Pharmaceuticals, Inc. |
Direct application system and method for the delivery of bioactive compositions and formulations
|
|
CA2889833A1
(en)
*
|
2012-10-28 |
2014-05-01 |
Revance Therapeutics, Inc. |
Compositions and methods for safe treatment of rhinitis
|
|
EP2792684A1
(en)
|
2013-04-15 |
2014-10-22 |
Lipotec, S.A. |
Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
|
|
CN103479627A
(zh)
|
2013-05-16 |
2014-01-01 |
武汉光谷百桥国际生物科技有限公司 |
一种血管紧张素ii的i型受体拮抗剂在促进毛发生长方面的应用
|
|
WO2015168564A1
(en)
|
2014-05-01 |
2015-11-05 |
Anterios, Inc. |
Methods to treat, prevent, and improve skin conditions
|
|
AU2015252947B2
(en)
|
2014-05-01 |
2020-07-09 |
Anterios, Inc. |
Demonstrable efficacy across or within patient populations
|
|
CN115998740A
(zh)
|
2014-10-29 |
2023-04-25 |
萨姆森临床私人有限公司 |
毛发过度脱落的检测和治疗
|
|
AU2016343748A1
(en)
|
2015-10-29 |
2018-05-17 |
Revance Therapeutics, Inc. |
Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect
|
|
US20170209553A1
(en)
|
2016-01-22 |
2017-07-27 |
Transderm, Inc. |
Delivery of botulinum with microneedle arrays
|
|
AU2017360346B2
(en)
|
2016-11-21 |
2023-11-23 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
|
BR112021004542A2
(pt)
|
2018-09-13 |
2021-06-08 |
Eirion Therapeutics, Inc. |
inibidores do inibidor de ativador de plasminogênio 1 (pai-1) e usos para os mesmos
|
|
CA3112549A1
(en)
|
2018-09-13 |
2020-03-19 |
Eirion Therapeutics, Inc. |
Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
|
|
BR112021009554A2
(pt)
|
2018-12-03 |
2021-08-17 |
Eirion Therapeutics, Inc. |
aplicação melhorada de agentes grandes
|
|
CA3139983A1
(en)
|
2019-05-14 |
2020-11-19 |
Eirion Therapeutics, Inc. |
Delaying peak effect and/or extending duration of response
|